- Report
- December 2025
- 473 Pages
Global
From €4328EUR$4,799USD£3,711GBP
- Report
- December 2025
- 250 Pages
Global
From €4328EUR$4,799USD£3,711GBP
- Report
- October 2025
- 997 Pages
Global
From €4328EUR$4,799USD£3,711GBP
- Report
- May 2026
- 527 Pages
Global
From €4464EUR$4,950USD£3,828GBP
- Report
- August 2026
- 440 Pages
Global
From €4464EUR$4,950USD£3,828GBP
- Report
- July 2026
- 517 Pages
Global
From €4464EUR$4,950USD£3,828GBP
- Report
- July 2026
- 265 Pages
Global
From €4464EUR$4,950USD£3,828GBP
- Report
- July 2026
- 269 Pages
Global
From €4328EUR$4,799USD£3,711GBP
- Report
- July 2026
- 190 Pages
Global
From €2706EUR$3,000USD£2,320GBP
- Report
- October 2025
- 130 Pages
Global
From €2976EUR$3,300USD£2,552GBP
- Report
- December 2025
- 132 Pages
Global
From €4419EUR$4,900USD£3,789GBP
- Report
- June 2026
- 165 Pages
Global
From €2029EUR$2,250USD£1,740GBP
- Report
- June 2026
- 290 Pages
Global
From €3743EUR$4,150USD£3,209GBP
- Report
- June 2026
- 278 Pages
Global
From €3743EUR$4,150USD£3,209GBP
- Report
- June 2026
- 289 Pages
Global
From €3743EUR$4,150USD£3,209GBP
- Report
- March 2026
- 295 Pages
Global
From €3743EUR$4,150USD£3,209GBP
- Report
- September 2026
- 457 Pages
Global
From €5276EUR$5,850USD£4,524GBP
- Report
- September 2026
- 269 Pages
Global
From €5276EUR$5,850USD£4,524GBP
- Report
- September 2026
- 231 Pages
Global
From €5276EUR$5,850USD£4,524GBP
- Report
- September 2026
- 273 Pages
Global
From €5276EUR$5,850USD£4,524GBP

The biopharmaceuticals market is a sector of the pharmaceutical industry that focuses on the development and production of drugs derived from biological sources. These drugs are typically produced using recombinant DNA technology, which involves the manipulation of genetic material to create proteins and other molecules with therapeutic properties. Biopharmaceuticals are used to treat a wide range of diseases, including cancer, HIV/AIDS, and autoimmune disorders.
Biopharmaceuticals are typically more expensive to produce than traditional pharmaceuticals, but they offer a number of advantages, such as improved efficacy and fewer side effects. They are also more targeted, meaning they can be used to treat specific conditions more effectively.
Some of the major companies in the biopharmaceuticals market include Amgen, Biogen, Celgene, Gilead Sciences, and Novartis. These companies are involved in the development and production of a wide range of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Show Less Read more